Developer docs
API playgroundTry for free, no card

Search company profiles

Sheikh Shakhbout Medical City

Full company profile

uuid0006pnw

Namestring
Sheikh Shakhbout Medical City
Legal namestring
Sheikh Shakhbout Medical City
Websiteurl
ssmc.ae
Company typeenum
Private
Founded yearint
2019
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersAbu Dhabi, United Arab Emirates
HQ citystring
Abu Dhabi
HQ countrystring
United Arab Emirates
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
acute care hospital, specialty medical services, clinical research trials, medical education programs, healthcare simulation training
Industry1 code
1Health Systems Strengthening & Universal Health Coverage (UHC) Partnerships
CodeHLAJAOALPrimaryYes
NAICS code4 codes
  • General Medical and Surgical Hospitals622110
  • General Medical and Surgical Hospitals6221
  • General Medical and Surgical Hospitals62211
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
SIC code3 codes
  • Services-General Medical & Surgical Hospitals, Nec8062
  • Services-Hospitals8060
  • Services-Health Services8000
Product category
Acute Care Hospital Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Patient Care Services
TypeSubscription Recurring
Description

Revenue generated from comprehensive medical services including consultations, procedures, surgeries, diagnostic tests, inpatient and outpatient care, emergency services, and specialized treatments across all hospital departments and clinics.

ssmc.ae
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Standard hospital services
ModelOtherBilling cadencePay-as-you-go
Notes

Pricing is quote-based and not publicly disclosed. Services are covered through various insurance plans including Thiqa, with a network of insurance partners listed on the hospital website.

ssmc.ae
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 5 records shown
1Neuroscience Institute
Description

A specialized institute offering cutting-edge care for neurological conditions at SSMC.

ssmc.ae
+4 more records
Core offering1 text field

Sheikh Shakhbout Medical City (SSMC) is an acute-care medical city in Abu Dhabi delivering comprehensive inpatient, outpatient, surgical, emergency, and critical care services across multiple specialties including surgery, medicine, pediatrics, obstetrics/gynecology, oncology, and clinical imaging. It operates specialized centers (Neuroscience Institute, IBD Centre, Burn Centre, Barakatna Clinic) and runs an academic medical program that integrates clinical care with graduate medical education, continuing medical education, simulation-based training, and Phase 1-4 clinical trials.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 400 catheter and device-based cardiac interventions performed in 2025
+2 more records
Product overview1 text field

Sheikh Shakhbout Medical City (SSMC) operates as a comprehensive acute-care medical city in Abu Dhabi, offering integrated healthcare services through specialized departments (Surgery, Medicine, Pediatrics, Critical Care, Emergency Medicine, Clinical Imaging, Obstetrics/Gynecology, Anesthesiology, Radiation Oncology, Physical Medicine and Rehabilitation). SSMC provides specialized centers including the Neuroscience Institute, IBD Centre, Burn Centre, and Barakatna Clinic for senior care. The organization combines clinical care with academic medical education through its Graduate Medical Education Centre, CME Centre, and Centre of Innovation and Medical Simulation. Research capabilities include a Clinical Trials Unit conducting Phase 1-4 trials, AI-based diagnostic systems (ClinGRAD, MAGNET-AD), and gene therapy programs. Patient services extend to executive health programs, travel clinic, and international patient services.

Product and service14 records
1Sheikh Shakhbout Medical City (SSMC)
CategoryAcute Care Hospital
Description

Major acute-care medical facility in Abu Dhabi offering comprehensive inpatient, outpatient, surgical, emergency, and critical care services across specialties including surgery, medicine, pediatrics, oncology, and clinical imaging.

2Neuroscience Institute
CategorySpecialty Center
Description

Specialized institute at SSMC providing care for neurological conditions including neurology, neurosurgery, and interventional neuroradiology.

3IBD Centre
CategorySpecialty Center
Description

Inflammatory Bowel Disease Centre providing comprehensive care for Crohn's disease and ulcerative colitis, including diagnosis, treatment, clinical trials, and patient education.

4Barakatna Clinic
CategorySpecialty Clinic
Description

Specialized senior care clinic under the Barakatna Initiative providing comprehensive one-hour multidisciplinary assessments for patients aged 65+, covering pharmacy, physiotherapy, nutrition, psychology, cognition, balance, and continence care; insurance limited to Thiqa plans.

5Burn Centre
CategorySpecialty Center
Description

Specialized burn treatment facility, the only burn and trauma centre in Abu Dhabi, part of the Department of Emergency Medicine.

6Travel Health Clinic
CategorySpecialty Clinic
Description

Clinic offering pre-travel health consultations, vaccinations, and destination-specific health advice for international travelers.

7Executive Health Programme
CategoryWellness Program
Description

Comprehensive health assessment and wellness program designed for executives and high-profile individuals, providing time-efficient preventive screening and check-ups.

8GI Genius Screening Program
CategoryDiagnostic Service
Description

Gastrointestinal screening program using AI-powered GI Genius technology for enhanced detection and diagnosis during endoscopic procedures.

9Clinical Trials Unit (CTU)
CategoryClinical Research
Description

Specialized research unit conducting Phase 1-4 clinical trials, observational studies, AI/Machine Learning studies, and gene therapy trials; recognized as one of two centers in the Middle East chosen for gene therapy clinical trials.

10Centre of Innovation and Medical Simulation (CIMS)
CategoryMedical Education
Description

Simulation-based medical training center offering high-fidelity adult, pediatric, and obstetric manikins, virtual reality simulators, task trainers, and surgical simulators for training healthcare professionals.

11Graduate Medical Education Centre
CategoryMedical Education
Description

Medical education center providing residency, fellowship, and continuing medical education programs for physicians, with a teaching faculty of over 350 physicians.

12CASGEVY Gene Therapy
CategoryGene Therapy
Description

First CRISPR-Cas9 based gene therapy in the UAE administered at SSMC for inherited blood disorders including sickle cell disease and beta thalassemia, developed in partnership with Vertex Pharmaceuticals.

13ClinGRAD and MAGNET-AD AI Systems
CategoryAI Diagnostic
Description

AI diagnostic systems based on graph neural networks developed jointly with MBZUAI to improve early detection and classification of dementia and Alzheimer's disease, supporting clinicians with diagnosis and disease progression prediction.

14International Patient Services
CategoryPatient Services
Description

Dedicated services for international patients seeking specialized medical care, including visa assistance, travel arrangements, accommodation support, and language interpretation.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-05
Description

Partnership for administration of CASGEVY (exagamglogene autotemcel), the UAE's first gene therapy for sickle cell disease and beta thalassemia using CRISPR-Cas9 technology. The therapy targets root genetic causes of inherited blood disorders and was administered at SSMC in January 2026.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-05
Description

Partnership under supervision of Department of Health - Abu Dhabi for gene therapy treatments including CASGEVY for sickle cell disease and beta thalassemia.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-27
Description

Joint development of AI systems ClinGRAD and MAGNET-AD based on graph neural networks to improve early detection and classification of dementia and Alzheimer's disease. SSMC contributed clinical expertise and data for the AI systems.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-10-23
Description

Phase 2 clinical trial for Sknjct-004 non-invasive treatment of basal cell carcinoma (BCC) of the skin, conducted at SSMC as one of six UAE study sites.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-12-01
Description

Ongoing collaborative projects in AI research, contributing to the hospital's research ecosystem and academic mission.

6China Medical University Hospital (CMUH), Taiwan
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-12-01
Description

AI mega studies collaboration in endocrinology (osteoporosis) and cardiology (congestive heart failure) research.

ssmc.ae
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-12-01
Description

Preferred site for biotech and pharma investors including JP Morgan Chase; advisory role in DoH's Abu Dhabi's Life Sciences Innovation Hub with PWC; DoH grant awardee for 5 grants in AI and IoT research.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cleveland Clinic Abu Dhabi is a multispecialty academic medical centre on Al Maryah Island, Abu Dhabi, operating under a Cleveland Clinic license. It is the closest direct competitor to SSMC in complex tertiary care, medical education, and research within the same emirate.

TypeDirect peer
Description

SKMC is a flagship SEHA tertiary hospital in Abu Dhabi sharing the same public payer ecosystem and academic medical mission. It is a direct peer in complex care, residency training, and clinical research within Abu Dhabi.

TypeRegional player
Description

Burjeel is a leading UAE private hospital group with flagship tertiary facilities in Abu Dhabi. It is a regional peer competing for complex medical cases, international patients, and physician talent in the same geography.

TypeRegional player
Description

Mediclinic operates multiple hospitals and clinics across the UAE, including Abu Dhabi. It is a regional peer offering comparable multi-specialty acute care with a strong international reputation, competing for insured and expatriate patients.

TypeRegional player
Description

King's College Hospital London – Dubai is a UAE-based academic hospital licensed from a UK teaching hospital, combining complex tertiary care with medical education and research. It is a regional peer in the academic-medical-centre model SSMC pursues.

TypeEmerging player
Description

Mubadala Health is an Abu Dhabi government-backed integrated healthcare platform operating specialty and tertiary assets in the same emirate as SSMC. It is an emerging peer pursuing similar complex-care, research, and medical-tourism ambitions in Abu Dhabi.

TypeRegional player
Description

Aga Khan University Hospital is a teaching hospital in Karachi with multiple satellite facilities across South Asia and East Africa. It is a regional peer in academic medical care, residency training, and clinical research under a mission-driven model similar to SSMC.

TypeBroad incumbent
Description

Cleveland Clinic is the US parent of Cleveland Clinic Abu Dhabi and one of the world's leading academic health systems. It is a broad incumbent whose operating model, clinical standards, and academic structure are explicitly replicated by SSMC's competitors and benchmarked by SSMC itself.

TypeBroad incumbent
Description

Mayo Clinic is a global benchmark for integrated clinical care, research, and medical education. It is a broad incumbent representing the academic-medical-centre archetype SSMC is positioned against in advanced tertiary and quaternary services.

TypeRegional player
Description

NMC Healthcare is one of the largest private hospital operators in the UAE. It is a regional peer in multi-specialty acute care across Abu Dhabi and the wider UAE, with comparable referral networks and insurance relationships.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sheikh Shakhbout Medical City

Acute Care Hospital Servicesssmc.ae

Sheikh Shakhbout Medical City firmographics

Firmographics
Name
Sheikh Shakhbout Medical City
Legal name
Sheikh Shakhbout Medical City
Website
https://ssmc.ae
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

Sheikh Shakhbout Medical City industry classification

Industry
Product category
Acute Care Hospital Services
NAICS
General Medical and Surgical Hospitals (622110), General Medical and Surgical Hospitals (6221), General Medical and Surgical Hospitals (62211), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)
SIC
Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060), Services-Health Services (8000)
akta.pro primary industry
Health Systems Strengthening & Universal Health Coverage (UHC) Partnerships (HLAJAOAL)

Keywords

  • Acute care hospital
  • Specialty medical services
  • Clinical research trials
  • Medical education programs
  • Healthcare simulation training

Where Sheikh Shakhbout Medical City is headquartered

Location

Headquarters

HQ city
Abu Dhabi
HQ country
United Arab Emirates
HQ region
Middle East

Offices1 record

Markets served

Sheikh Shakhbout Medical City business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Patient Care Services: Revenue generated from comprehensive medical services including consultations, procedures, surgeries, diagnostic tests, inpatient and outpatient care, emergency services, and specialized treatments across all hospital departments and clinics.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goStandard hospital services

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Sheikh Shakhbout Medical City product offering

Product offering

Core offering

Sheikh Shakhbout Medical City (SSMC) is an acute-care medical city in Abu Dhabi delivering comprehensive inpatient, outpatient, surgical, emergency, and critical care services across multiple specialties including surgery, medicine, pediatrics, obstetrics/gynecology, oncology, and clinical imaging. It operates specialized centers (Neuroscience Institute, IBD Centre, Burn Centre, Barakatna Clinic) and runs an academic medical program that integrates clinical care with graduate medical education, continuing medical education, simulation-based training, and Phase 1-4 clinical trials.

Product overview

Sheikh Shakhbout Medical City (SSMC) operates as a comprehensive acute-care medical city in Abu Dhabi, offering integrated healthcare services through specialized departments (Surgery, Medicine, Pediatrics, Critical Care, Emergency Medicine, Clinical Imaging, Obstetrics/Gynecology, Anesthesiology, Radiation Oncology, Physical Medicine and Rehabilitation). SSMC provides specialized centers including the Neuroscience Institute, IBD Centre, Burn Centre, and Barakatna Clinic for senior care. The organization combines clinical care with academic medical education through its Graduate Medical Education Centre, CME Centre, and Centre of Innovation and Medical Simulation. Research capabilities include a Clinical Trials Unit conducting Phase 1-4 trials, AI-based diagnostic systems (ClinGRAD, MAGNET-AD), and gene therapy programs. Patient services extend to executive health programs, travel clinic, and international patient services.

Differentiator

Problem solved

Functional benefit

Brands

  • Neuroscience Institute: A specialized institute offering cutting-edge care for neurological conditions at SSMC.
  • IBD Centre
  • Barakatna Clinic
  • Burns Center of Excellence
  • Memory Clinic

Products and services

  • Sheikh Shakhbout Medical City (SSMC) Major acute-care medical facility in Abu Dhabi offering comprehensive inpatient, outpatient, surgical, emergency, and critical care services across specialties including surgery, medicine, pediatrics, oncology, and clinical imaging.
  • Neuroscience Institute Specialized institute at SSMC providing care for neurological conditions including neurology, neurosurgery, and interventional neuroradiology.
  • IBD Centre Inflammatory Bowel Disease Centre providing comprehensive care for Crohn's disease and ulcerative colitis, including diagnosis, treatment, clinical trials, and patient education.
  • Barakatna Clinic Specialized senior care clinic under the Barakatna Initiative providing comprehensive one-hour multidisciplinary assessments for patients aged 65+, covering pharmacy, physiotherapy, nutrition, psychology, cognition, balance, and continence care; insurance limited to Thiqa plans.
  • Burn Centre Specialized burn treatment facility, the only burn and trauma centre in Abu Dhabi, part of the Department of Emergency Medicine.
  • Travel Health Clinic Clinic offering pre-travel health consultations, vaccinations, and destination-specific health advice for international travelers.
  • Executive Health Programme Comprehensive health assessment and wellness program designed for executives and high-profile individuals, providing time-efficient preventive screening and check-ups.
  • GI Genius Screening Program Gastrointestinal screening program using AI-powered GI Genius technology for enhanced detection and diagnosis during endoscopic procedures.
  • Clinical Trials Unit (CTU) Specialized research unit conducting Phase 1-4 clinical trials, observational studies, AI/Machine Learning studies, and gene therapy trials; recognized as one of two centers in the Middle East chosen for gene therapy clinical trials.
  • Centre of Innovation and Medical Simulation (CIMS) Simulation-based medical training center offering high-fidelity adult, pediatric, and obstetric manikins, virtual reality simulators, task trainers, and surgical simulators for training healthcare professionals.
  • Graduate Medical Education Centre Medical education center providing residency, fellowship, and continuing medical education programs for physicians, with a teaching faculty of over 350 physicians.
  • CASGEVY Gene Therapy First CRISPR-Cas9 based gene therapy in the UAE administered at SSMC for inherited blood disorders including sickle cell disease and beta thalassemia, developed in partnership with Vertex Pharmaceuticals.
  • ClinGRAD and MAGNET-AD AI Systems AI diagnostic systems based on graph neural networks developed jointly with MBZUAI to improve early detection and classification of dementia and Alzheimer's disease, supporting clinicians with diagnosis and disease progression prediction.
  • International Patient Services Dedicated services for international patients seeking specialized medical care, including visa assistance, travel arrangements, accommodation support, and language interpretation.

Quantifiable outcome

  • Over 400 catheter and device-based cardiac interventions performed in 2025
  • +2 more outcomes

Companies that use Sheikh Shakhbout Medical City

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles5 records

Sheikh Shakhbout Medical City technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Sheikh Shakhbout Medical City partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • Vertex PharmaceuticalscoreStrategic or Co-development Partner · 5 January 2026Partnership for administration of CASGEVY (exagamglogene autotemcel), the UAE's first gene therapy for sickle cell disease and beta thalassemia using CRISPR-Cas9 technology. The therapy targets root genetic causes of inherited blood disorders and was administered at SSMC in January 2026.
  • Abu Dhabi Stem Cells CentercoreStrategic or Co-development Partner · 5 January 2026Partnership under supervision of Department of Health - Abu Dhabi for gene therapy treatments including CASGEVY for sickle cell disease and beta thalassemia.
  • Mohamed bin Zayed University of Artificial Intelligence (MBZUAI)coreStrategic or Co-development Partner · 27 October 2025Joint development of AI systems ClinGRAD and MAGNET-AD based on graph neural networks to improve early detection and classification of dementia and Alzheimer's disease. SSMC contributed clinical expertise and data for the AI systems.
  • Medicus Pharma Ltd.minorStrategic or Co-development Partner · 23 October 2025Phase 2 clinical trial for Sknjct-004 non-invasive treatment of basal cell carcinoma (BCC) of the skin, conducted at SSMC as one of six UAE study sites.
  • Khalifa UniversitycoreStrategic or Co-development Partner · 1 December 2023Ongoing collaborative projects in AI research, contributing to the hospital's research ecosystem and academic mission.
  • China Medical University Hospital (CMUH), TaiwancoreStrategic or Co-development Partner · 1 December 2023AI mega studies collaboration in endocrinology (osteoporosis) and cardiology (congestive heart failure) research.
  • Department of Health - Abu DhabicoreStrategic or Co-development Partner · 1 December 2023Preferred site for biotech and pharma investors including JP Morgan Chase; advisory role in DoH's Abu Dhabi's Life Sciences Innovation Hub with PWC; DoH grant awardee for 5 grants in AI and IoT research.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Sheikh Shakhbout Medical City competitors and assessment

Company assessment

Direct peers

  • Cleveland Clinic Abu Dhabi: Cleveland Clinic Abu Dhabi is a multispecialty academic medical centre on Al Maryah Island, Abu Dhabi, operating under a Cleveland Clinic license. It is the closest direct competitor to SSMC in complex tertiary care, medical education, and research within the same emirate.
  • Sheikh Khalifa Medical City (SEHA/SKMC): SKMC is a flagship SEHA tertiary hospital in Abu Dhabi sharing the same public payer ecosystem and academic medical mission. It is a direct peer in complex care, residency training, and clinical research within Abu Dhabi.

Regional players

  • Burjeel Hospital Abu Dhabi: Burjeel is a leading UAE private hospital group with flagship tertiary facilities in Abu Dhabi. It is a regional peer competing for complex medical cases, international patients, and physician talent in the same geography.
  • Mediclinic Middle East: Mediclinic operates multiple hospitals and clinics across the UAE, including Abu Dhabi. It is a regional peer offering comparable multi-specialty acute care with a strong international reputation, competing for insured and expatriate patients.
  • King's College Hospital London – Dubai: King's College Hospital London – Dubai is a UAE-based academic hospital licensed from a UK teaching hospital, combining complex tertiary care with medical education and research. It is a regional peer in the academic-medical-centre model SSMC pursues.
  • Aga Khan University Hospital: Aga Khan University Hospital is a teaching hospital in Karachi with multiple satellite facilities across South Asia and East Africa. It is a regional peer in academic medical care, residency training, and clinical research under a mission-driven model similar to SSMC.
  • NMC Healthcare: NMC Healthcare is one of the largest private hospital operators in the UAE. It is a regional peer in multi-specialty acute care across Abu Dhabi and the wider UAE, with comparable referral networks and insurance relationships.

Emerging players

Broad incumbents

  • Cleveland Clinic (US): Cleveland Clinic is the US parent of Cleveland Clinic Abu Dhabi and one of the world's leading academic health systems. It is a broad incumbent whose operating model, clinical standards, and academic structure are explicitly replicated by SSMC's competitors and benchmarked by SSMC itself.
  • Mayo Clinic: Mayo Clinic is a global benchmark for integrated clinical care, research, and medical education. It is a broad incumbent representing the academic-medical-centre archetype SSMC is positioned against in advanced tertiary and quaternary services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Sheikh Shakhbout Medical City social profiles

Digital presence

Sheikh Shakhbout Medical City compliance and trust

Trust signal

Compliance3 records

Sheikh Shakhbout Medical City financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sheikh Shakhbout Medical City leadership team

Management profile

Number of profiles

Profiles13 records

Sheikh Shakhbout Medical City funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sheikh Shakhbout Medical City M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sheikh Shakhbout Medical City

What does Sheikh Shakhbout Medical City do?

Sheikh Shakhbout Medical City (SSMC) is an acute-care medical city in Abu Dhabi delivering comprehensive inpatient, outpatient, surgical, emergency, and critical care services across multiple specialties including surgery, medicine, pediatrics, obstetrics/gynecology, oncology, and clinical imaging. It operates specialized centers (Neuroscience Institute, IBD Centre, Burn Centre, Barakatna Clinic) and runs an academic medical program that integrates clinical care with graduate medical education, continuing medical education, simulation-based training, and Phase 1-4 clinical trials.

Is Sheikh Shakhbout Medical City a public or private company?

Sheikh Shakhbout Medical City is a private company. It is classified as corporate owned and is currently operating.

When was Sheikh Shakhbout Medical City founded?

Sheikh Shakhbout Medical City was founded in 2019. It employs 1,001 to 5,000 people.

Where is Sheikh Shakhbout Medical City based?

Sheikh Shakhbout Medical City is headquartered in Abu Dhabi, United Arab Emirates, in the Middle East region.

How does Sheikh Shakhbout Medical City make money?

One revenue line is on record: patient Care Services.

Who are Sheikh Shakhbout Medical City's main competitors?

Direct peers on record are Cleveland Clinic Abu Dhabi and Sheikh Khalifa Medical City (SEHA/SKMC). Regional players are Burjeel Hospital Abu Dhabi, Mediclinic Middle East, King's College Hospital London – Dubai, Aga Khan University Hospital and NMC Healthcare. Mubadala Health (including Cleveland Clinic Abu Dhabi, Imperial College London Diabetes Centre) is listed as an emerging player. Broad incumbents are Cleveland Clinic (US) and Mayo Clinic.

Does Sheikh Shakhbout Medical City have an API?

No public API is recorded for Sheikh Shakhbout Medical City.

What industry is Sheikh Shakhbout Medical City in?

Sheikh Shakhbout Medical City's product category is Acute Care Hospital Services. Its primary akta.pro industry code is HLAJAOAL, Health Systems Strengthening & Universal Health Coverage (UHC) Partnerships. Its NAICS code is 622110 and its SIC code is 8062.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GulfNewsEmpowered to lead: How Emirati women are shaping the UAE’s futureEmirati women are increasingly leading in specialized healthcare fields, with over 415 women at Sheikh Shakhbout Medical City holding 30 leadership positions. The National Policy for Empowerment of Emirati Women 2023-2031 and family support measures like the Nafis programme are cited as key enablers. The author argues that continued investment will expand their influence in future industries.GulfNewsHow Abu Dhabi doctors solved a 40kg weight-loss mystery with robotic surgeryDoctors at Sheikh Shakhbout Medical City (SSMC) in the UAE successfully treated a patient with Median Arcuate Ligament Syndrome using robotic surgery after months of diagnostic uncertainty. The multidisciplinary team performed a minimally invasive procedure to relieve compression on the celiac artery, resulting in the patient's recovery from severe symptoms including 40kg weight loss. This case highlights the efficacy of robotic-assisted surgery and collaborative specialist care for rare vascular conditions.The NationalAbu Dhabi to test high-tech mattress using AI to ease sleep apnoeaThe Department of Health – Abu Dhabi, Sheikh Shakhbout Medical City, and sleep technology company Eight Sleep have launched a 12-week clinical study to test an AI-powered mattress that detects and responds to positional sleep apnoea by prompting users to change position. The trial will recruit 30 patients and connect Eight Sleep's monitoring technology with Abu Dhabi's intelligent health system to analyse sleep and physiological signals alongside real-time health data. The mattress, which uses automatic vibrations to encourage position changes, offers a less invasive alternative to traditional CPAP treatment and represents an expansion of Eight Sleep's technology from consumer sleep optimization into medical applications.The NationalUAE mother of three enjoys new lease of life after pioneering surgery to fix mystery conditionA UAE mother of three named Iman, who was seriously injured in a road accident in Oman in 2011, suffered undiagnosed urinary incontinence for over a decade until pioneering surgery at Sheikh Shakhbout Medical City in Abu Dhabi in 2023 revealed multiple vesicovaginal fistulas caused by displaced pelvic bone. Dr. Manal Elredy and her team successfully diagnosed and treated the condition, which had been misdiagnosed as overactive bladder for years, giving Iman a new lease of life after she had lost hope. The case highlights the importance of investigating persistent urinary incontinence following major trauma, with Dr. Elredy noting that roughly two-thirds of such patients require surgery.GulfNewsPureHealth’s Dh6.33b UAE spending boost powers local industry growthPureHealth, the largest healthcare group in the Middle East, announced it has exceeded Dh6.33 billion in local procurement spend since joining the Ministry of Industry and Advanced Technology's National In-Country Value programme in 2022, representing a near threefold increase from Dh2.25 billion in 2025. The milestone, highlighted during Make it in the Emirates 2026, underscores the Group's role in advancing UAE economic diversification, with entities including SEHA, Sheikh Shakhbout Medical City, Daman, PureLab, and Rafed contributing to ICV performance. PureHealth remains on track to achieve its Dh13 billion ICV commitment by 2032 through system-wide supply chain strengthening and support for national industries.GulfNewsPureHealth’s SEHA and Sheikh Shakhbout Medical City Earn AAHRPP Accreditation, Boosting Abu Dhabi’s Global Clinical Research HubPureHealth's SEHA and Sheikh Shakhbout Medical City have received full three-year accreditation from the Association for the Accreditation of Human Research Protection Programs, one of the highest global recognitions in human research protection. The accreditation confirms both entities meet strict international standards for ethics, safety and oversight in clinical studies, with their research work conducted under the Abu Dhabi Health Research Centre supporting over 200 active studies across 16 hospitals, primary care centers and laboratories. The recognition is expected to strengthen Abu Dhabi's position as a growing center for healthcare research and attract global clinical trials to the region.GulfNewsAbu Dhabi’s Sheikh Shakhbout Medical City renews Baby-Friendly Hospital accreditationSheikh Shakhbout Medical City (SSMC) in Abu Dhabi has successfully renewed its Baby-Friendly Hospital accreditation, reaffirming its commitment to implementing the World Health Organization's Ten Steps to Successful Breastfeeding across its maternity, postnatal, and neonatal departments. The hospital reported a significant increase in outpatient visits, with the Obstetrics and Gynecology Department growing from 15,854 visits in 2024 to approximately 22,001 in 2025, and the Neonatal Department rising from 1,025 to around 1,302 visits. The accreditation underscores the hospital's focus on evidence-based maternal and newborn care, with structured staff training programs and lactation support services designed to improve health outcomes for mothers and infants.GulfNewsAbu Dhabi Health Chief Visits Injured Patients Amid Regional Crisis, Affirms Resilient Healthcare SystemMansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi (DoH), visited Sheikh Shakhbout Medical City to review the condition of patients injured in recent regional events and their treatment plans, accompanied by senior health officials and coordinated with the Emergencies, Crises and Disasters Management Centre – Abu Dhabi (ECDC). During the visit, Al Mansoori met with patients and their families, received briefings from medical teams, and highlighted the role of the Unified Medical Operations Command Centre (UMOC) in enabling real-time coordination across Abu Dhabi's healthcare ecosystem. Al Mansoori reaffirmed that Abu Dhabi's health system remains fully operational and resilient, committed to maintaining continuity of care amid regional tensions.GulfNewsStroke Strikes Younger in UAE: New Studies Highlight Rising Health ConcernsTwo independent medical studies conducted at Ibrahim Bin Hamad Obaidullah Hospital in Ras Al Khaimah and at Fatima College of Health Sciences and Sheikh Shakhbout Medical City in Abu Dhabi have found that stroke is affecting UAE residents more than a decade younger than in Western countries, with mean patient ages of 55.7 and 40 years respectively. The research, covering 837 patients (2020–2024) and 51 patients (October 2024–March 2025), identified high rates of hypertension (75.2%), diabetes (49.5%), and obesity as major preventable risk factors driving this trend. Researchers are calling for routine screening in younger adults and improved prevention efforts across the UAE.PurehealthSheikh Shakhbout Medical City first hospital in Abu Dhabi to receive Academic Medical Centre Accreditation from Joint Commission InternationalSheikh Shakhbout Medical City (SSMC), a subsidiary of PureHealth, has become the first hospital in Abu Dhabi and the UAE to receive the Joint Commission International's Academic Medical Centre Accreditation with the Gold Seal of Approval. The accreditation recognizes SSMC's excellence across medical professional education, clinical research protocols, and quality improvement and patient safety programmes. SSMC's CEO stated this achievement reflects the hospital's commitment to maintaining global standards of healthcare and positions it among elite healthcare institutions worldwide.